| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.11. | CAMSING HEALTHCARE LIMITED: RESPONSE TO SGX QUERIES | 3 | SGX Company Announcements | ||
| 23.10. | CAMSING HEALTHCARE LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF ANNUAL GENERAL MEETING HELD ON 29 SEPTEMBER 2025 | 1 | SGX Company Announcements | ||
| 30.09. | CAMSING HEALTHCARE LIMITED: ANNUAL REPORTS AND RELATED DOCUMENTS | 2 | SGX Company Announcements | ||
| 29.09. | CAMSING HEALTHCARE LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 12.09. | CAMSING HEALTHCARE LIMITED: GENERAL ANNOUNCEMENT::QUARTERLY UPDATE PURSUANT TO RULE 1313(2) OF THE SGX-ST LISTING MANUAL | 2 | SGX Company Announcements | ||
| 12.09. | CAMSING HEALTHCARE LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::SECOND QUARTER AND/OR HALF YEARLY RESULTS | 2 | SGX Company Announcements | ||
| 12.09. | CAMSING HEALTHCARE LIMITED: ANNUAL REPORTS AND RELATED DOCUMENTS | 4 | SGX Company Announcements | ||
| 12.09. | CAMSING HEALTHCARE LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY | 2 | SGX Company Announcements | ||
| CAMSING HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 12.09. | CAMSING HEALTHCARE LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::AUDITOR'S COMMENTS OF ACCOUNTS | 2 | SGX Company Announcements | ||
| 12.09. | CAMSING HEALTHCARE LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::DISCREPANCIES BETWEEN UNAUDITED AND AUDITED ACCOUNTS | 2 | SGX Company Announcements | ||
| 13.06. | CAMSING HEALTHCARE LIMITED: ASSET ACQUISITIONS AND DISPOSALS::ANNOUNCEMENT PURSUANT TO RULE 706A OF THE SGX-ST LISTING MANUAL | 1 | SGX Company Announcements | ||
| 13.06. | CAMSING HEALTHCARE LIMITED: GENERAL ANNOUNCEMENT::QUARTERLY UPDATE PURSUANT TO RULE 1313(2) OF THE SGX-ST LISTING MANUAL | 5 | SGX Company Announcements | ||
| 13.06. | CAMSING HEALTHCARE LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FIRST QUARTER RESULTS | 1 | SGX Company Announcements | ||
| 11.06. | CAMSING HEALTHCARE LIMITED: WAIVER::REJECTION BY SGX REGCO OF THE COMPANY'S APPLICATION FOR AN EXTENSION OF TIME | 1 | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 43,510 | +1,92 % | EQS-PVR: Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Siemens Healthineers AG
Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
01.12.2025 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,040 | +0,08 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,790 | +1,79 % | IPO Stock Of The Week: Health Care Leader BrightSpring Falls Back Into Buying Range | ||
| PROCEPT BIOROBOTICS | 35,860 | +1,21 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS | 47,720 | -0,60 % | Fresenius-Aktie: Kaufen! | Die Aktie des Gesundheitskonzerns Fresenius hat sich in den zurückliegenden Wochen doch wieder spürbar von den Mehrjahreshochs Ende Oktober entfernt. An den mittel- bis langfristigen Aussichten für... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,550 | +0,77 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| GENEDX | 158,96 | -1,85 % | Cathie Wood's ARK sells Iridium, buys GeneDx and WeRide stock | ||
| PROGYNY | 24,020 | -0,54 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| BETA BIONICS | 29,380 | -2,07 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| NUTEX HEALTH | 160,95 | +2,65 % | Nutex Health extends share repurchase plan | ||
| GERRESHEIMER | 25,860 | -1,52 % | Gerresheimer vor Abstieg - Newcomer vor SDAX-Debüt? | Die nächste Indexüberprüfung am deutschen Aktienmarkt steht an. Die Entscheidung wird die Deutsche Börse heute nach Börsenschluss bekanntgeben. Nach mehreren Gewinnwarnungen und einem massiven Kursverfall... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 43,440 | +0,32 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,310 | +1,92 % | Aveanna Healthcare stock price target raised to $13 by Raymond James | ||
| GOODRX | 2,710 | -1,45 % | HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? | ||
| CERIBELL | 19,720 | +2,98 % | Ceribell Reports Third Quarter 2025 Financial Results | SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen |